Commissioned by Nature’s Bioceuticals and in collaboration with Good2Grow Organic, Livingstone ventures, along with a team of experts, wrote a plan to convert a mushroom farm into a high-tech, medicinal Cannabis facility in Denmark.
The facility consists of a large number of cells that vary in size but due to special isolation and conditioning systems, are ideally suited for growing certified medicinal Cannabis.
Currently, there is a provisional license for research on Cannabis cultivation, but the expectation is that in 2024 a license will be granted for commercial production.
Livingstone ventures cooperates in this project with specialists from Canada, Ireland, the Netherlands, Slovenia, and Cannada.
